Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Care Options
SEATTLE, June 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that a summary of the pixantrone Phase III clinical data that were presented at American Society of Clinical Oncology (ASCO) 2009 Annual Meeting on June 1, 2009 is now available
New AAHC Toolkit Available to Optimize Clinical Research Administration
Groundbreaking Product is a Must for Clinical Trials Management
WASHINGTON, July 21 /PRNewswire-USNewswire/ -- The Association of
Academic Health Centers (AAHC) today launched a new Clinical Trials
Administration Toolkit designed to assist academic health center leaders,
GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
Data being made available
on NCI Database Could Save Drug Development Time and Capital for Other Research Institutions
PHILADELPHIA, June 20 /PRNewswire-FirstCall/ -- Marking another
positive step in the collaborative fight against cancer, GlaxoSmithKline
(NYSE: GSK ) announced to...
Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15)
SEATTLE, May 9 /PRNewswire-USNewswire/ -- The risk of the two major
prostate diseases, cancer and benign prostatic hyperplasia (BPH), can be
reduced by changes in lifestyle, such as avoiding smoking, maintaining a
normal weight and eating a healthy diet. Alan Kristal, Dr.P.H., associate
Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
BRIDGEWATER, N.J., March 11 /PRNewswire/ -- The totality of scientific
data submitted in recent months to the U.S. Food and Drug Administration
(FDA) in preparation for the March 13th Oncologic Drugs Advisory Committee
Meeting (ODAC) reaffirms that erythropoiesis-stimulating agents (ESAs) are
Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
The once-daily HIV treatment would greatly increase effectiveness for
patients, but Gilead Sciences and Merck and Co. have failed to register it in countries where it is needed most
LOS ANGELES, Sept. 10 /PRNewswire-USNewswire/ -- AIDS Healthcare
Foundation (AHF) today calle...
New Resource Available for People With Lymphoma
FAIRFAX, Va., Aug. 2 /PRNewswire-USNewswire/ -- The American Society
for Therapeutic Radiology and Oncology has published the brochure Radiation
Therapy for Lymphoma, a short treatment guide to assist people coping with
Hodgkin's and non-Hodgkin's lymphoma. The brochure outlines the major
BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
ARLINGTON, Va., May 5 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. Despite a sluggish economy and cuts being made to laboratory budgets, the market for stem cell research products is expected to increa...
New Gene Methylation Test for Prostate Cancer Available
RARITAN, N.J., May 16 /PRNewswire/ -- Veridex, LLC announced today that
its licensing collaborator, Laboratory Corporation of America Holdings
(LabCorp), has commercially launched a new gene methylation test for
prostate cancer. The new assay uses the biological specificity of 'DNA
Survival Data Available from Erbitux Study in First-Line Treatment
of Advanced Head and Neck Cancer
NEW YORK--(BUSINESS WIRE)--Apr 4, 2007 - ImClone Systems
Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE:
BMY) announced today that a first line Phase III study of
ERBITUX(R) (Cetuximab) combined with platinum-based chemotherapy
met the primary endpoint of increasing overall surv...
Survival Data Available From Erbitux Study in First-Line Treatment
of Advanced Head and Neck Cancer
-- First large, randomized Phase III study of ERBITUX with
chemotherapy in recurrent and/or metastatic head and neck cancer
meets primary endpoint of improving overall survival --
NEW YORK, April 04, 2007 /PRNewswire-FirstCall/ -- ImClone
Systems Incorporated and Bristol-Myers Squibb Company annou...
Data Available from Erbitux Phase III Study in First-Line Treatment
of Advanced Pancreatic Cancer
NEW YORK, April 10, 2007 /PRNewswire-FirstCall/ -- ImClone
Systems Incorporated and Bristol-Myers Squibb Company today
announced that a Phase III study of ERBITUX(R) (Cetuximab) plus
gemcitabine (a chemotherapy) in patients with locally advanced
unresectable or metastatic pancreatic cancer did not...
Positive Results Prompt US National Cancer Institute to Make
Gleevec Available To Patients in Post-Surgical Gist Study
- Gleevec found to dramatically reduce the risk of cancer returning
after surgery for Kit-positive gastrointestinal stromal tumors
EAST HANOVER, N.J., April 12, 2007 /PRNewswire/ -- Investigators
will begin offering Gleevec(R) (imatinib mesylate)* tablets to
patients receiving placebo in a ...
Data Available From Erbitux Phase III Study in First-Line Treatment
of Advanced Lung Cancer
NEW YORK, July 12, 2007 /PRNewswire-FirstCall/ -- ImClone
Systems Incorporated and Bristol-Myers Squibb Company today
announced results from an open-label Phase III study of ERBITUX(R)
(Cetuximab) plus a taxane and carboplatin in the first-line
treatment for metastatic non-small cell lung cancer (...
Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
... that we pursue the vaccine licensure pathway made available
to us, while at the same time, continue the import... data, immunogenicity and safety data will be made available
through clinical studies. Sanofi Pasteur will test... influenza A(H1N1) 2009 vaccine clinical trials is available
at www.clinicaltrials.gov .
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
...x as a single agent for the treatment of EGFR-expressing, metastatic colorectal carcinoma is based on progression-free survival. Currently no data are available
that demonstrate an improvement in disease-related symptoms or increased survival with Vectibix. Vectibix has not shown a treatment benefit for patien...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...ipomersen and support our efforts to make the drug available
to patients in need," said Ms. Parshall.
"... in severe hypercholesterolemia patients should be available
at the time of these U.S. submissions and may prov...t www.isispharm.com . A webcast replay will be available
for a limited time at the same address.
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
...apidly, particularly at the femoral neck, since hip fractures are one of the most serious complications of osteoporosis and an area in which currently available
osteoporosis treatments are weak."
"These data are consistent with the clinical hypothesis for BA058--greater gains in BMD at the critical ana...
NewCardio Announces Master Services Agreement With Dedicated Phase I
...other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available
information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements contained herein are ...
Labopharm files New Drug Submission with Health Canada for novel antidepressant
... molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available
in 17 countries around the world, including the U.S., Canada, major European markets and Australia. The Company's second product, a novel formulation ...
NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
...rocess from gene sequence to cGMP manufacturing is available
on the Novavax website (www.Novavax.com).
...s around the world by addressing gaps in currently available
vaccine technologies," added Dr. Rahul Singhvi, Pr...proaches. Additional information about Novavax is available
at www.novavax.com and in the company's various fi...
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
...al: (866) 831-6270 (U.S.); (617) 213-8858 (international)
Passcode: 25099763 (Howard Robin is the host)
An audio replay will also be available
shortly following the call through Wednesday, August 19, 2009 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) ...
Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
Mercury's technology and of the growing appreciation of AMPK as a novel drug
target for metabolic diseases. The development of an orally available
activator of AMPK has the potential to be a first-in-class therapeutic for
type 2 diabetes, hyperlipidemia, and a number of indications in onco...
Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
...d Severe Chronic Idiopathic Neutropenia. Reprints of both publications are available
Background on MDS and TELINTRA
MDS is a heterog... death in human leukemia cell lines. Additional information on TELINTRA is available
at www.telik.com .
Telik, Inc. of Palo Alto,...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
...r this use in the U.S. INVEGA(R) SUSTENNA(TM) is available
in milligrams (mg) of paliperidone palmitate in do...oorly water-soluble compounds. More information is available
at www.elandrugtechnologies.com .
(This pr...this Form 10-K, as well as subsequent filings, are available
online at www.sec.gov , www.jnj.com or on reque...
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
...h other chemotherapies. Access recently announced data from a recurrent ovarian cancer trial that showed that ProLindac was more active than currently available
platinum drugs in that patient population, and that the drug was very well tolerated.
ProLindac is a novel DACH platinum drug that has shown to...
Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
...ently with the FDA and other regulatory agencies to
make velaglucerase alfa available
as soon as possible to help meet the needs
of the Gaucher community."
...or Type 1 Gaucher patients. The
prospect of having another treatment option available
to help patients
achieve therapeutic goals is very important and is welcome...
OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
... disease progression, and six patients were alive at time of data presentation. Median progression free survival was 3.3 months.
This poster is available
OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which was formerly known as XYOTA...
John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden
...t, because I know the money generated will go directly to help get medicine to those who need it."
Tickets to this exclusive (RED)ZONE area are available
by visiting www.johnlegend.com/red and entering the special access code as prompted - tickets are $66.00 each and are subject to limited availabil...
Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
...estors may listen to the call by dialing (888) 806-6208 from locations in the U.S. and (913) 312-0640 from outside the U.S. The webcast replay will be available
for at least 72 hours following the call.
PSI-7851 is a uridine nucleotide analog currently in development for the treatment...
FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia
..., including more than two million people in the United States and more than four million people in Europe. Although there are a number of medications available
for patients, treatment success for any antipsychotic agent can be unpredictable because patients often respond differently to various medications. A...
Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
...ing the estrogen receptors in the breast cells and can reduce the risk of a breast cancer recurrence by up to 50 percent. It's the only anti-estrogen available
for prevention of breast cancer recurrence in pre-menopausal women and is one of several anti-estrogens used to treat post-menopausal breast cancer pa...
Is Your Hair Taking a Break?
...own to be very effective in women as well. Both the 2% and 5% solutions are available
over-the-counter. While minoxidil does not grow new hair, it works by prolo...d by their hair loss can find help through the many support groups that are available
to patients on the Internet.
Headquartered in Schaumburg, Ill., the...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
...ional education and research. More information is available
at www.nof.org .
Society for Women's H...sis and treatment of disease. More information is available
at www.womenshealthresearch.org .
Amer...cacy, education and research. More information is available
at www.aauw.org .
American Business Wo...
Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
...cluding MAESTRO-02 and MAESTRO-03 - and review the available
data from these studies. MAESTRO-02 is an open-lab...h our clinical team to evaluate these data and the available
data from MAESTRO-02 and MAESTRO-03 to determine o...ut relapses(vii). There are few treatment options available
for these patients(viii).
About Lilly ...
Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
...pressed in the referenced publication. The Phase 3 clinical trial data presented and published to date reflect only a portion of the totality of data available
from Phase 3 studies of BZA/CE and, accordingly, do not represent the totality of data and other information that may affect regulatory review and com...
Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture
...re, Sensitive Skin and Gentle Exfoliating variants. The body washes will be available
in August 2009 at food, drug, mass and club retailers. For more information...anti-perspirant/deodorants, body mists, hair care and styling aids. Dove is available
nationwide in food, drug and mass outlet stores.
About Unilever ...
Cyberonics Provides Update on Depression Post-Approval Study
Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available
at www.cyberonics.com and www.vnstherapy.com.
Safe harbor statem...ements contained in this press release are based upon information presently available
to us and assumptions that we believe to be reasonable. We are not assumin...
Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
...wed for a total of five years.
The Anaconda system is commercially available
outside the U.S. where it has been implanted in nearly 4000 patients. It r...cal repair and endovascular repair. Endovascular repair using commercially available
devices has been associated with shorter recovery times, reduced hospital s...
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
...rtilage and bone. Rigel's R788 is a novel, orally available
syk kinase inhibitor designed to interrupt the cel...resentation related to the TASKi3 trial results is available
on Rigel's website homepage at http://www.rigel.co...e passcode 13318888. A replay of the call will be available
at approximately 10:00 pm EDT/7:00 pm PDT on July ...